CN100379763C - Crosslinked Poria cocos polysaccharide and its preparation method and application - Google Patents
Crosslinked Poria cocos polysaccharide and its preparation method and application Download PDFInfo
- Publication number
- CN100379763C CN100379763C CNB200610018145XA CN200610018145A CN100379763C CN 100379763 C CN100379763 C CN 100379763C CN B200610018145X A CNB200610018145X A CN B200610018145XA CN 200610018145 A CN200610018145 A CN 200610018145A CN 100379763 C CN100379763 C CN 100379763C
- Authority
- CN
- China
- Prior art keywords
- linked
- cross
- polysaccharide
- poria cocos
- pachyman
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000008599 Poria cocos Nutrition 0.000 title claims abstract description 34
- 241001619444 Wolfiporia cocos Species 0.000 title claims abstract description 34
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 229920001282 polysaccharide Polymers 0.000 title abstract description 41
- 239000005017 polysaccharide Substances 0.000 title abstract description 41
- 150000004676 glycans Chemical class 0.000 title abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 239000000843 powder Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000004132 cross linking Methods 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011259 mixed solution Substances 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 42
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 9
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000000967 suction filtration Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 claims 4
- 239000008141 laxative Substances 0.000 claims 1
- 230000002475 laxative effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 16
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 abstract description 12
- 239000007884 disintegrant Substances 0.000 abstract description 11
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 150000004804 polysaccharides Chemical class 0.000 description 34
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 10
- 238000004062 sedimentation Methods 0.000 description 10
- 239000007795 chemical reaction product Substances 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 229940124531 pharmaceutical excipient Drugs 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 4
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 241000576755 Sclerotia Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002522 swelling effect Effects 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 241000282461 Canis lupus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000383833 Pachyphyllum Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明涉及交联茯苓多糖及其制备方法和用途。所述交联茯苓多糖由下法制得:茯苓多糖与2-5倍茯苓多糖质量的水或醇混合得到混合液,调pH值9~11之间,加入茯苓多糖质量的0.1%-0.5%的环氧氯丙烷,在35-45℃交联反应6-10小时,然后中和、过滤、洗涤、冷冻干燥得到交联茯苓多糖。本发明所述的交联茯苓多糖流动性好,吸水性强,并具有较高的松密度和膨胀性,可作为优良的高效崩解剂。交联茯苓多糖在崩解过程中呈粉末状均匀分散,增加了片剂的崩解能力,提高了片剂的崩解效率。The invention relates to cross-linked pachyrhythmic polysaccharide and its preparation method and application. The cross-linked polysaccharide is prepared by the following method: the polysaccharide is mixed with water or alcohol 2-5 times the mass of the polysaccharide to obtain a mixed solution, the pH value is adjusted between 9 and 11, and 0.1%-0.5% of the mass of the polysaccharide is added Epichlorohydrin, cross-linking reaction at 35-45 DEG C for 6-10 hours, and then neutralizing, filtering, washing, and freeze-drying to obtain cross-linked pachyrhin. The cross-linked poria cocos polysaccharide of the invention has good fluidity, strong water absorption, high bulk density and expansibility, and can be used as an excellent high-efficiency disintegrant. The cross-linked polysaccharide is evenly dispersed in powder form during the disintegration process, which increases the disintegration ability of the tablet and improves the disintegration efficiency of the tablet.
Description
技术领域: Technical field:
本发明涉及交联茯苓多糖及其制备方法和用途。The invention relates to cross-linked pachyrhythmic polysaccharide and its preparation method and application.
背景技术: Background technique:
药用辅料是药物制剂存在的物质基础,是生产药物制剂的必备材料,因此世界各国对开发新型药用辅料均很重视。Pharmaceutical excipients are the material basis for the existence of pharmaceutical preparations and the necessary materials for the production of pharmaceutical preparations. Therefore, all countries in the world attach great importance to the development of new pharmaceutical excipients.
片剂是一种使用最广泛的口服固体制剂,要提高片剂的质量,选用好的辅料是个关键。填充剂和崩解剂是普通片剂中最主要的辅料,这些辅料的选择直接影响片剂的内在质量和药物的疗效。目前常用的辅料主要有淀粉类,纤维素类,海藻酸类,陶土类,PVP类,树胶类等。Tablets are the most widely used oral solid preparations. To improve the quality of tablets, choosing good excipients is the key. Fillers and disintegrants are the most important excipients in ordinary tablets, and the selection of these excipients directly affects the internal quality of the tablet and the curative effect of the drug. At present, the commonly used auxiliary materials mainly include starch, cellulose, alginic acid, clay, PVP, gum and so on.
随着药物制剂朝着“三效”(高效、速效、长效)和“三小”(毒性小、副作用小、剂量小)的方向发展,使得新辅料,尤其是具有良好缓释、控释作用的天然药用辅料的开发更具意义,其中对天然高分子多糖的开发研究特别引人注目,前景广阔。With the development of pharmaceutical preparations in the direction of "three effects" (high-efficiency, quick-acting, long-acting) and "three small" (low toxicity, small side effects, small dose), new excipients, especially those with good sustained-release and controlled-release The development of natural pharmaceutical excipients with different effects is more meaningful, and the research on the development of natural polymer polysaccharides is particularly eye-catching and has broad prospects.
茯苓为多孔菌科植物茯苓poría cocos(Schw.)Wolf的干燥菌核。其结构为一种主链为线性β(1→3)糖苷键连接的葡聚糖,支链由9~10外葡萄糖残基通过β(1→6)糖苷键连接,具有类似淀粉的高分子多糖结构。茯苓为一种传统的中药,不少学者对其进行了广泛的研究,但大量实验证明,茯苓多糖作为抗肿瘤等药物其药理作用并不明显。因此,尝试将茯苓多糖开发为一种天然高分子辅料,具有很大的可行性、创新性以及广阔的应用前景。Poria cocos is the dried sclerotia of Polyporaceae plant Poria cocos (Schw.) Wolf. Its structure is a kind of glucan whose main chain is connected by linear β(1→3) glycosidic bonds, and the branch chain is connected by 9 to 10 outer glucose residues through β(1→6) glycosidic bonds. It has a starch-like polymer polysaccharide structure. Poria cocos is a traditional Chinese medicine. Many scholars have conducted extensive research on it, but a large number of experiments have proved that the pharmacological effect of Poria cocos polysaccharide as an anti-tumor drug is not obvious. Therefore, trying to develop Poria cocos polysaccharide as a natural polymer excipient has great feasibility, innovation and broad application prospects.
发明内容: Invention content:
本发明目的在于提供一种交联茯苓多糖及其制备方法和用途,所制得的交联茯苓多糖作为片剂崩解剂,在崩解过程中呈粉末状均匀分散,可以增加片剂的崩解能力,提高片剂的崩解效率。The object of the present invention is to provide a kind of cross-linked pachymans and its preparation method and application. The obtained cross-linked pachyrans is used as tablet disintegrating agent, and it is evenly dispersed in powder form during the disintegration process, which can increase the disintegration of tablets. Disintegration ability, improve tablet disintegration efficiency.
本发明提供的技术方案是:交联茯苓多糖,由下法制得:茯苓多糖与2-5倍茯苓多糖质量的水或醇混合得到混合液,调pH值9~11之间,加入茯苓多糖质量的0.1%-0.5%的环氧氯丙烷,在35-45℃交联反应6-10小时,然后中和、过滤、洗涤、冷冻干燥得到交联茯苓多糖;或者,将茯苓菌核磨成60-200目粉末,溶于0.5-5wt%的氢氧化钠或氢氧化钾溶液中,温度控制在0℃~5℃,搅拌至稠状,放置10-20小时,抽滤得到滤液,调pH值9~11之间,加入茯苓菌核粉末质量的0.05%-0.25%的环氧氯丙烷,在35-45℃交联反应6-10小时,然后中和、过滤、洗涤、冷冻干燥得到交联茯苓多糖。The technical solution provided by the present invention is: cross-linked polysaccharide, which is obtained by the following method: mix polysaccharide with water or alcohol 2-5 times the quality of polysaccharide to obtain a mixed solution, adjust the pH value between 9 and 11, and add the quality of polysaccharide 0.1%-0.5% epichlorohydrin, cross-linking reaction at 35-45 ° C for 6-10 hours, then neutralize, filter, wash, and freeze-dry to obtain cross-linked pachyrhin; or, grind Poria cocos sclerotia into 60 -200 mesh powder, dissolved in 0.5-5wt% sodium hydroxide or potassium hydroxide solution, the temperature is controlled at 0°C-5°C, stirred until thick, left for 10-20 hours, filtered to obtain the filtrate, adjust the pH value Between 9 and 11, add 0.05%-0.25% epichlorohydrin based on the mass of Poria cocos sclerotia powder, conduct a cross-linking reaction at 35-45°C for 6-10 hours, then neutralize, filter, wash, and freeze-dry to obtain cross-linking Poria cocos polysaccharide.
本发明所述的新型高分子药用辅料中的交联茯苓多糖为以β(1→3)糖苷键为主链,β(1→6)糖苷键为支链的多孔菌科植物茯苓的衍生物,可用作片剂崩解剂。The cross-linked Poria cocos polysaccharide in the new polymer pharmaceutical excipient described in the present invention is a derivative of Poria cocos with β (1 → 3) glycosidic bonds as the main chain and β (1 → 6) glycosidic bonds as branched chains. It can be used as a tablet disintegrant.
本发明所制备的交联茯苓多糖的交联度的测定方法采用沉降积法。具体方法参见张友松,变性淀粉生产与应用手册[M],北京:中国轻工业出版社,1999。The method for measuring the degree of cross-linking of the cross-linked pachyranan prepared by the present invention adopts the sedimentation method. For specific methods, refer to Zhang Yousong, Handbook of Production and Application of Modified Starch [M], Beijing: China Light Industry Press, 1999.
本发明通过将所制备的交联茯苓多糖的不同方面的考察来研究其应用性能:The present invention studies its application performance by investigating different aspects of the prepared cross-linked pachyrhin:
1.考察交联茯苓多糖的溶胀性。1. Investigate the swelling property of cross-linked pachymansin.
2.通过固定圆锥底法考察所制备的交联茯苓多糖的流动性。2. The fluidity of the prepared cross-linked pachyranan was investigated by the fixed cone bottom method.
3.通过固定架自由落体法考察所制备的交联茯苓多糖的松密度。3. Investigate the bulk density of the prepared cross-linked pachyrhin by the free fall method of the fixed frame.
4.将所制备的交联茯苓多糖应用于硫酸钙空白片剂的崩解剂,考察其崩解特性。4. The prepared cross-linked pachymane was applied to the disintegrant of calcium sulfate blank tablet, and its disintegration characteristics were investigated.
交联茯苓多糖在片剂中可用于湿法制粒,也可加入干颗粒中。对疏水性药物崩解难度较大的片子可采取外加入法;对于不易成型的片子采取内加入法;对于不好崩解而又不易成型的片子采用内外两者兼顾的方法加入。Cross-linked pachyranan can be used in wet granulation in tablets, or it can be added to dry granules. The external addition method can be adopted for tablets that are difficult to disintegrate hydrophobic drugs; the internal addition method can be used for tablets that are difficult to form;
上述实验研究表明,交联茯苓多糖流动性好,能满足片剂生产的基本需要。另外,交联茯苓多糖吸水性强,并具有较高的松密度和膨胀性,在崩解过程中呈粉末状均匀分散,增加了片剂的崩解能力,提高了片剂的崩解效率。因此本发明所述的新型高分子药用辅料交联茯苓多糖为优良的高效崩解剂。The above experimental research shows that the cross-linked polysaccharide has good fluidity and can meet the basic needs of tablet production. In addition, the cross-linked Poria cocos polysaccharide has strong water absorption, high bulk density and expansibility, and is evenly dispersed in powder form during the disintegration process, which increases the disintegration ability of the tablet and improves the disintegration efficiency of the tablet. Therefore, the novel high molecular pharmaceutical excipient cross-linked polysaccharide of the present invention is an excellent high-efficiency disintegrant.
具体实施方式: Detailed ways:
下列实施例将进一步说明本发明。The following examples further illustrate the invention.
实施例一:交联茯苓多糖1的制备Example 1: Preparation of Crosslinked Pachyranan 1
1.茯苓多糖的制备1. Preparation of Poria cocos polysaccharide
将市售新鲜茯苓菌核磨成粉末,过60目筛,取600g溶于0.5wt%的NaOH溶液中(茯苓粉末与NaOH溶液的用量质量比为1∶100),温度控制在0℃~5℃,搅拌至稠状,放置过夜,抽滤得到滤液,之后用10%醋酸中和滤液,0℃~5℃放置过夜,抽滤得到白色沉淀,依次用水、乙醇、丙酮乙醚洗涤沉淀,20℃~50℃干燥,即得到茯苓多糖。Grind commercially available fresh Poria cocos sclerotium into powder, pass through a 60-mesh sieve, take 600 g and dissolve in 0.5 wt% NaOH solution (the mass ratio of Poria cocos powder to NaOH solution is 1:100), and the temperature is controlled at 0°C to 5°C. ℃, stirred until thick, left overnight, filtered with suction to obtain the filtrate, then neutralized the filtrate with 10% acetic acid, placed overnight at 0°C to 5°C, filtered with suction to obtain a white precipitate, washed the precipitate with water, ethanol, and acetone ethyl ether in sequence, at 20°C Dried at ~50°C to obtain pachyphyllin.
2.制备交联茯苓多糖12. Preparation of Cross-linked Pachyranan 1
在30g茯苓多糖中加入2倍茯苓多糖质量的水,搅拌均匀后,加入5%氢氧化钠水溶液,使整个体系pH值为9,机械搅拌,反应温度达到35℃时加入茯苓多糖质量的0.1%的环氧氯丙烷,交联反应6小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为7.1mL的交联茯苓多糖1。Add 2 times of the quality of pachyrhynch in 30g of pachyrhiza, after stirring evenly, add 5% aqueous sodium hydroxide solution to make the pH of the whole system be 9, stir mechanically, add 0.1% of the mass of pachycarp when the reaction temperature reaches 35°C Epichlorohydrin, cross-linking reaction for 6 hours, and then use 1mol/L dilute sulfuric acid to neutralize the reaction product to a pH value of 5-6, filter, wash, and freeze-dry to obtain a sedimentation volume of 7.1 mL of cross-linked pachyrhin 1.
实施例二:交联茯苓多糖2的制备Embodiment two: the preparation of cross-linked pachymansin 2
将市售新鲜茯苓菌核磨成粉末,过60目筛,取60g溶于2wt%的氢氧化钠溶液中(茯苓粉末与NaOH溶液的用量质量比为1∶100),温度控制在0℃~5℃,搅拌至稠状,放置过夜,抽滤得到滤液,调pH值为10,机械搅拌,反应温度达到35℃时加入0.03克的环氧氯丙烷,交联反应8小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.9mL的交联茯苓多糖2。Grind commercially available fresh Poria cocos sclerotium into powder, pass through a 60-mesh sieve, take 60g and dissolve in 2wt% sodium hydroxide solution (the mass ratio of Poria cocos powder to NaOH solution is 1: 100), and the temperature is controlled at 0° C. 5°C, stirred until thick, left overnight, suction filtered to obtain the filtrate, adjusted the pH value to 10, mechanically stirred, when the reaction temperature reached 35°C, added 0.03 g of epichlorohydrin, cross-linked for 8 hours, and then used 1mol/ 1 L of dilute sulfuric acid neutralized the reaction product to a pH value of 5-6, filtered, washed, and freeze-dried to obtain cross-linked pachyan 2 with a sedimentation volume of 6.9 mL.
实施例三:制备交联茯苓多糖3Embodiment 3: Preparation of cross-linked pachymansin 3
在30g茯苓多糖(市售)中加入5倍茯苓多糖质量的水,搅拌均匀后,加入5%氢氧化钠水溶液,使整个体系pH值为11,机械搅拌,反应温度达到45℃时加入茯苓多糖质量的0.1%的环氧氯丙烷,交联反应10小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.7mL的交联茯苓多糖3。Add 5 times the quality of pachyrhizan in 30g pachyrhizan (commercially available), after stirring evenly, add 5% sodium hydroxide aqueous solution, make the pH of the whole system be 11, stir mechanically, add pachyrhin when the reaction temperature reaches 45°C 0.1% epichlorohydrin by mass, cross-linking reaction for 10 hours, and then neutralize the reaction product with 1mol/L dilute sulfuric acid to a pH value of 5-6, filter, wash, freeze-dry to obtain a sedimentation volume of 6.7mL Cross-linked pachymansin3.
实施例四:制备交联茯苓多糖4Embodiment 4: Preparation of cross-linked pachymansin 4
在30g茯苓多糖(茯苓多糖的制备同实施例一)中加入5倍茯苓多糖质量的醇,搅拌均匀后,加入5%氢氧化钠水溶液,使整个体系pH值为10,机械搅拌,反应温度达到35℃时加入茯苓多糖质量的0.2%的环氧氯丙烷,交联反应10小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.6mL的交联茯苓多糖4。Add 5 times the alcohol of pachyrhizan quality in 30g pachyrhiza (preparation of pachyrhin is the same as in Example 1), after stirring evenly, add 5% aqueous sodium hydroxide solution to make the pH value of the whole system 10, mechanically stir, and the reaction temperature reaches At 35°C, add 0.2% epichlorohydrin based on the mass of the polysaccharide, cross-link for 10 hours, then use 1mol/L dilute sulfuric acid to neutralize the reaction product to a pH value of 5-6, filter, wash, and freeze-dry to obtain The sedimentation volume was 6.6 mL of cross-linked pachyranan 4.
实施例五:制备交联茯苓多糖5Embodiment 5: Preparation of cross-linked pachymansin 5
在30g茯苓多糖(市售)中加入2倍茯苓多糖质量的醇,搅拌均匀后,加入5%氢氧化钠水溶液,使整个体系pH值为11,机械搅拌,反应温度达到40℃时加入茯苓多糖质量的0.2%的环氧氯丙烷,交联反应6小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.5mL的交联茯苓多糖5。Add alcohol with 2 times the quality of pachyrhiza in 30g of pachyrhizan (commercially available), stir evenly, add 5% sodium hydroxide aqueous solution, make the pH of the whole system be 11, stir mechanically, add pachyrhin when the reaction temperature reaches 40°C 0.2% epichlorohydrin by mass, cross-linking reaction for 6 hours, then neutralize the reaction product with 1mol/L dilute sulfuric acid to a pH value of 5-6, filter, wash, freeze-dry to obtain a sedimentation volume of 6.5mL Cross-linked pachyranan 5.
实施例六:制备交联茯苓多糖6Embodiment 6: Preparation of cross-linked pachymansin 6
在30g茯苓多糖(市售)中加入2倍茯苓多糖质量的水或醇,搅拌均匀后,加入一定体积的5%氢氧化钠水溶液,使整个体系pH值为9,机械搅拌,反应温度达到45℃时加入茯苓多糖质量的0.2%的环氧氯丙烷,交联反应8小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.3mL的交联茯苓多糖6。Add water or alcohol with 2 times the quality of pachyphyllin (commercially available) in 30g pachyphyllum, after stirring evenly, add a certain volume of 5% sodium hydroxide aqueous solution to make the pH value of the whole system 9, mechanically stir, and the reaction temperature reaches 45 Add 0.2% epichlorohydrin of the mass of pachyphyllin at ℃, cross-linking reaction for 8 hours, then neutralize the reaction product with 1mol/L dilute sulfuric acid to a pH value of 5-6, filter, wash, and freeze-dry to obtain sedimentation Cross-linked pachyranan 6 with a volume of 6.3 mL.
实施例七:制备交联茯苓多糖7Embodiment 7: Preparation of cross-linked pachymansin 7
1.茯苓多糖的制备:将市售新鲜茯苓菌核磨成粉末,过200目筛,取600g溶于5wt%的KOH溶液中(茯苓粉末与KOH溶液的用量质量比为1∶200),温度控制在0℃~5℃,搅拌至稠状,放置过夜,抽滤得到滤液,之后用10%醋酸中和滤液,0℃~5℃放置过夜,抽滤得到白色沉淀,依次用水、乙醇、丙酮乙醚洗涤沉淀,20℃~50℃干燥,即得到茯苓多糖。1. The preparation of Poria cocos polysaccharide: commercially available fresh Poria cocos sclerotium is ground into powder, crosses 200 mesh sieves, gets 600g to be dissolved in the KOH solution of 5wt% (the consumption mass ratio of Poria cocos powder and KOH solution is 1: 200), temperature Control the temperature at 0°C to 5°C, stir until thick, leave overnight, and obtain the filtrate by suction filtration, then neutralize the filtrate with 10% acetic acid, place it at 0°C to 5°C overnight, and obtain white precipitate by suction filtration, followed by water, ethanol, acetone The precipitate was washed with ether, and dried at 20°C to 50°C to obtain pachyrhin.
2.交联茯苓多糖7的制备2. Preparation of Crosslinked Pachyranan 7
在30g茯苓多糖中加入5倍茯苓多糖质量的醇,搅拌均匀后,加入5%氢氧化钠水溶液,使整个体系pH值为11,机械搅拌,反应温度达到35℃时加入茯苓多糖质量的0.5%的环氧氯丙烷,交联反应8小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.1mL的交联茯苓多糖7。Add 5 times the alcohol of the quality of the polysaccharide in 30g of the polysaccharide, after stirring evenly, add 5% sodium hydroxide aqueous solution, make the pH value of the whole system be 11, stir mechanically, add 0.5% of the quality of the polysaccharide when the reaction temperature reaches 35°C Epichlorohydrin, cross-linking reaction for 8 hours, and then use 1mol/L dilute sulfuric acid to neutralize the reaction product to a pH value of 5-6, filter, wash, and freeze-dry to obtain a sedimentation volume of 6.1 mL of cross-linked pachyrhin 7.
实施例八:制备交联茯苓多糖8Embodiment 8: Preparation of cross-linked pachymansin 8
将市售新鲜茯苓菌核磨成粉末,过200目筛,取60g溶于5wt%的氢氧化钾溶液中(茯苓粉末与KOH溶液的用量质量比为1∶200),温度控制在0℃~5℃,搅拌至稠状,放置过夜,抽滤得到滤液,调pH值为9,机械搅拌,反应温度达到45℃时加入0.15克的环氧氯丙烷,交联反应10小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为5.9mL的交联茯苓多糖8。Grind commercially available fresh Poria cocos sclerotium into powder, pass through a 200 mesh sieve, take 60g and dissolve in 5wt% potassium hydroxide solution (the mass ratio of Poria cocos powder to KOH solution is 1:200), and the temperature is controlled at 0°C- 5°C, stirred until thick, left overnight, suction filtered to obtain the filtrate, adjusted the pH to 9, mechanically stirred, when the reaction temperature reached 45°C, added 0.15 g of epichlorohydrin, cross-linked for 10 hours, and then used 1mol/ The reaction product was neutralized with 1 L of dilute sulfuric acid to a pH value of 5-6, filtered, washed, and freeze-dried to obtain cross-linked pachyan 8 with a sedimentation volume of 5.9 mL.
实施例九:制备交联茯苓多糖9Embodiment 9: Preparation of cross-linked pachymansin 9
在30g茯苓多糖(茯苓多糖的制备同实施例八)中加入3倍茯苓多糖质量的水或醇,搅拌均匀后,加入5%氢氧化钠水溶液,使整个体系pH值为10,机械搅拌,反应温度达到45℃时加入茯苓多糖质量的0.5%的环氧氯丙烷,交联反应6小时,然后用1mol/L的稀硫酸将反应产物中和至pH值为5~6,过滤、洗涤、冷冻干燥得到沉降积为6.0mL的交联茯苓多糖9。Add 3 times the water or alcohol of the quality of the polysaccharide in 30g of the polysaccharide (the preparation of the polysaccharide is the same as in Example 8), after stirring evenly, add 5% aqueous sodium hydroxide solution to make the pH value of the whole system 10, mechanically stir, and react When the temperature reaches 45°C, add 0.5% epichlorohydrin based on the mass of the polysaccharide, cross-link for 6 hours, then neutralize the reaction product with 1mol/L dilute sulfuric acid to a pH value of 5-6, filter, wash, and freeze Dry to obtain cross-linked pachymane 9 with a sedimentation volume of 6.0 mL.
交联茯苓多糖溶胀性的研究Study on Swellability of Crosslinked Poria Cocos Polysaccharide
发明者将交联茯苓多糖样品1g加入到50ml量筒中,加蒸馏水50ml,剧烈振动,使粉末完全悬浮在水中,间隔10min后重复振动一次,静置48h后,除去上清液,测定吸水后样品的体积。以1g样品充分吸水后体积数据(5次相同实验平均值)表征交联茯苓多糖的溶胀性。The inventor added 1 g of the cross-linked pachyrhin sample to a 50 ml measuring cylinder, added 50 ml of distilled water, and vibrated vigorously to completely suspend the powder in the water, repeat the vibration once after an interval of 10 min, and remove the supernatant after standing for 48 h to measure the sample after water absorption. volume of. The swelling property of cross-linked pachymansin was characterized by the volume data (average value of 5 identical experiments) of 1 g sample after fully absorbing water.
表1几种崩解剂流动性的比较Table 1 Comparison of fluidity of several disintegrants
样品名 吸水后体积(mL)Sample name Volume after water absorption (mL)
PVPP 7.5PVPP 7.5
CMS-Na 19.5CMS-Na 19.5
L-HPC 9.5L-HPC 9.5
淀粉 无显著膨胀Starch No significant swelling
交联茯苓多糖1 28.0Cross-linked pachymansin 1 28.0
交联茯苓多糖2 32.8Cross-linked pachyranan 2 32.8
交联茯苓多糖3 30.1Cross-linked pachymansin 3 30.1
交联茯苓多糖4 20.2Cross-linked pachymansin 4 20.2
交联茯苓多糖5 29.0Cross-linked pachyan 5 29.0
交联茯苓多糖6 24.5Cross-linked pachyranan 6 24.5
交联茯苓多糖7 23.8Cross-linked pachymansin 7 23.8
交联茯苓多糖8 19.7Cross-linked pachymansin 8 19.7
交联茯苓多糖9 21.5Cross-linked pachymansin 9 21.5
交联茯苓多糖流动性的研究Study on Fluidity of Crosslinked Poria Cocos Polysaccharide
发明者采用固定圆锥底法,底部的直径3.5cm,漏斗出口直径为1.3cm,出口管长5.8cm,管端与底部的高度为4.5cm。对几种不同的崩解剂的流动性作了比较,测定结果见表2。The inventor adopts the fixed conical bottom method, the diameter of the bottom is 3.5cm, the diameter of the funnel outlet is 1.3cm, the length of the outlet pipe is 5.8cm, and the height between the pipe end and the bottom is 4.5cm. The fluidity of several different disintegrants was compared, and the results are shown in Table 2.
表2几种崩解剂流动性的比较Table 2 Comparison of fluidity of several disintegrants
样品名 休止角(度)Sample name Angle of repose (degrees)
PVPP 29.7PVPP 29.7
CMS-Na 34.6CMS-Na 34.6
L-HPC 61.7L-HPC 61.7
淀粉 50.8Starch 50.8
交联茯苓多糖系列(1~9) 29.7~31.3Cross-linked Poria cocos polysaccharide series (1~9) 29.7~31.3
交联茯苓多糖的松密度的研究Study on Bulk Density of Crosslinked Poria Cocos Polysaccharide
发明者采用100ml的量筒,每个样品均取30g,下落高度为15.1cm,在固定架内按自由落体方式震动5次进行测定,作相对比较。(数据为3次的平均值)The inventor adopts a 100ml measuring cylinder, takes 30g of each sample, and the drop height is 15.1cm, and vibrates 5 times in a free fall mode in a fixed frame for relative comparison. (Data is the average of 3 times)
表2几种崩解剂松密度的比较Table 2 Comparison of bulk density of several disintegrants
样品名 容积(ml)3 松密度(g/ml)Sample Name Volume (ml) 3 Bulk Density (g/ml)
PVPP 83.0 0.36PVPP 83.0 0.36
CMS-Na 53.3 0.56CMS-Na 53.3 0.56
L-HPC 68.1 0.44L-HPC 68.1 0.44
淀粉 53.0 0.57Starch 53.0 0.57
交联茯苓多糖系列(1~9) 59~66 0.45~0.51Cross-linked Poria cocos polysaccharide series (1~9) 59~66 0.45~0.51
交联茯苓多糖对空白片剂崩解特性的研究Study on Disintegration Characteristics of Blank Tablets with Crosslinked Poria Cocos Polysaccharide
发明者采用硫酸钙制备空白模型片。崩解剂的用量均为5%,采用内加崩解剂及等量3%HPMC浆湿制颗粒的方法,外加0.5%硬脂酸镁,用单冲压片机压制成直径10mm的素片。对几种不同的崩解剂作了比较,测定结果见表3。The inventors used calcium sulfate to prepare blank model sheets. The consumption of disintegrating agent is all 5%, adopts the method for internally adding disintegrating agent and equal amount 3% HPMC slurry wet granulation, adds 0.5% magnesium stearate, is compressed into the plain tablet of diameter 10mm with single-punch tablet machine. Several different disintegrants were compared, and the results are shown in Table 3.
表3几种崩解剂崩解时间的比较Table 3 Comparison of disintegration time of several disintegrants
崩解剂 硬度(kg) 崩解时间(s±SD)Disintegrant Hardness (kg) Disintegration time (s±SD)
硫酸钙空白 4.50 >1800Calcium sulfate blank 4.50 >1800
PVPP 4.49 193±34.5PVPP 4.49 193±34.5
CMS-Na 4.06 155±19.9CMS-Na 4.06 155±19.9
L-HPC 5.96 393±22.8L-HPC 5.96 393±22.8
淀粉 5.01 444±56.7Starch 5.01 444±56.7
交联茯苓多糖1 5.17 77±12.8Cross-linked polysaccharide 1 5.17 77±12.8
交联茯苓多糖2 4.36 76±8.6Cross-linked pachyranan 2 4.36 76±8.6
交联茯苓多糖3 4.22 98±13.3Cross-linked pachymansin 3 4.22 98±13.3
交联茯苓多糖4 4.58 33±6.4Cross-linked polysaccharide 4 4.58 33±6.4
交联茯苓多糖5 4.50 29±2.8Cross-linked pachyranan 5 4.50 29±2.8
交联茯苓多糖6 4.70 61±3.4Cross-linked pachyranan 6 4.70 61±3.4
交联茯苓多糖7 5.32 52±7.7Cross-linked pachymansin 7 5.32 52±7.7
交联茯苓多糖8 5.30 121±25.2Cross-linked polysaccharide 8 5.30 121±25.2
交联茯苓多糖9 5.93 49±3.7Cross-linked pachymansin 9 5.93 49±3.7
交联茯苓多糖流动性好,能满足片剂生产的基本需要。另外,交联茯苓多糖吸水性强,并具有较高的松密度和膨胀性,在崩解过程中呈粉末状均匀分散,增加了片剂的崩解能力,提高了片剂的崩解效率。The cross-linked pachyrhin has good fluidity and can meet the basic needs of tablet production. In addition, the cross-linked Poria cocos polysaccharide has strong water absorption, high bulk density and expansibility, and is evenly dispersed in powder form during the disintegration process, which increases the disintegration ability of the tablet and improves the disintegration efficiency of the tablet.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610018145XA CN100379763C (en) | 2006-01-12 | 2006-01-12 | Crosslinked Poria cocos polysaccharide and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200610018145XA CN100379763C (en) | 2006-01-12 | 2006-01-12 | Crosslinked Poria cocos polysaccharide and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1834109A CN1834109A (en) | 2006-09-20 |
CN100379763C true CN100379763C (en) | 2008-04-09 |
Family
ID=37002021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610018145XA Expired - Fee Related CN100379763C (en) | 2006-01-12 | 2006-01-12 | Crosslinked Poria cocos polysaccharide and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100379763C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102690364B (en) * | 2012-06-03 | 2014-07-02 | 柳州爱格富食品科技股份有限公司 | Ficoll synthesis process method |
CN102690365B (en) * | 2012-06-03 | 2014-07-02 | 柳州爱格富食品科技股份有限公司 | Process for preparing polysucrose |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1114655A (en) * | 1994-02-16 | 1996-01-10 | 沃尔夫瓦尔斯罗德有限公司 | Thermoplastic biodegradable polysaccharide derivatives, process for the manufacture thereof and use thereof |
CN1124249A (en) * | 1994-12-09 | 1996-06-12 | 沈阳药科大学 | Antineoplastic new poria polysaccharide water soluble derivative |
CN1190974A (en) * | 1995-07-17 | 1998-08-19 | 科迈德公司 | Polysaccharide gel composition |
CN1686561A (en) * | 2005-04-08 | 2005-10-26 | 武汉大学 | Modified natural polymer medical adjuvant, its preparation method and use |
-
2006
- 2006-01-12 CN CNB200610018145XA patent/CN100379763C/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1114655A (en) * | 1994-02-16 | 1996-01-10 | 沃尔夫瓦尔斯罗德有限公司 | Thermoplastic biodegradable polysaccharide derivatives, process for the manufacture thereof and use thereof |
CN1124249A (en) * | 1994-12-09 | 1996-06-12 | 沈阳药科大学 | Antineoplastic new poria polysaccharide water soluble derivative |
CN1190974A (en) * | 1995-07-17 | 1998-08-19 | 科迈德公司 | Polysaccharide gel composition |
CN1686561A (en) * | 2005-04-08 | 2005-10-26 | 武汉大学 | Modified natural polymer medical adjuvant, its preparation method and use |
Non-Patent Citations (2)
Title |
---|
交联魔芋葡甘聚糖微球的制备与表征. 罗立新等.林产化学与工业,第24卷第2期. 2004 * |
交联魔芋葡苷聚糖水凝胶包裹尿素的缓释效果. 邹群等.江苏化工,第33卷第2期. 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1834109A (en) | 2006-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100409899C (en) | Application of Poria cocos polysaccharide as a disintegrant in the preparation of pharmaceutical tablets | |
JP5031054B2 (en) | Low substituted hydroxypropyl cellulose and solid preparation containing the same | |
CN1970579A (en) | High substitution degree carboxymethyl indianbread polysaccharide and its preparation method and uses | |
CN104800290A (en) | Compound liquorice tablet and preparation method thereof | |
CN100379763C (en) | Crosslinked Poria cocos polysaccharide and its preparation method and application | |
CN106188324B (en) | Hydroxyethyl pachyman preparation and its as sustained release tablets framework material application | |
CN106243239B (en) | It is a kind of for improving the soluble small molecule beta-1,3-dextran of hepatitis immunity | |
CN107320456B (en) | N-acetyl-D-glucosamine capsule preparation and preparation method thereof | |
JPS648605B2 (en) | ||
CN102525976B (en) | Method for preparing strontium ranelate orally disintegrating tablets by using fluidized bed | |
Deshmukh et al. | Evaluation of binding properties of Butea monosperma Lam, Gum in tablet formulation | |
CN113480669B (en) | Preparation method of low-bulk-density croscarmellose sodium | |
CN100502950C (en) | Modified natural polymer pharmaceutical excipient and its preparation method and use | |
CN106214648B (en) | Erythromycin Ethylsuccinate Tablets and preparation method thereof | |
CN114344326A (en) | Application of plant pectin in product for treating gout | |
CN101623502B (en) | Preparation method of Ganodenic acid monomer Me cyclodextrin inclusion compound and of oral solid preparation | |
CN113768892A (en) | A kind of tablet composition for treating cardiovascular and preparation method thereof | |
Metta et al. | A REVIEW ON: DISINTEGRANTS AND SUPER DISINTEGRANTS WITH PROMINENCE ROLE OF STARCH AS DISINTEGRANT AND ITS METHODS OF MODIFICATION | |
CN103142522B (en) | Etoposide tablet | |
Agwamba et al. | Effect of carboxymethylation on porosity and flow property of mango starch | |
CN103083268B (en) | Polysaccharide sulfate dispersible tablet | |
CN113603808B (en) | Modified algin, preparation method and application thereof in preparation of medicine for promoting gastrointestinal peristalsis | |
CN107126438B (en) | Application of carboxymethyl chitosan in preparing product for reducing blood sugar | |
CN109276551A (en) | A kind of Ornidazole oral disintegrating tablet and preparation method thereof | |
CN110664762B (en) | A solid preparation containing propolis and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |